Procter & Gamble to Acquire Thorne Health Supplement Brand for $3.8 Billion
Procter & Gamble (P&G) CEO Shailesh Jejurikar announced that the consumer goods giant will acquire the dietary supplement brand Thorne for $3.8 billion. The deal is scheduled for official announcement on Tuesday and represents a significant move for P&G as it expands its health and wellness portfolio. Thorne is a well-established brand in the dietary supplement market, and its acquisition aligns with P&G's strategy to grow its presence in the health care sector. P&G already owns several dietary supplement brands, including Metamucil, Align probiotics, and New Chapter vitamins. These brands are managed under the company's Health Care business unit, which also oversees other well-known brands such as Oral-B and Vicks. This acquisition is expected to strengthen P&G's position in the rapidly growing health and wellness market, offering consumers a wider range of products focused on health and well-being.
This acquisition signifies P&G's strategic intent to deepen its penetration into the burgeoning health and wellness market, a sector increasingly driven by consumer demand for preventative health solutions. By integrating Thorne, P&G aims to leverage its extensive distribution networks and marketing prowess to scale Thorne's offerings, potentially enhancing its competitive standing against specialized health product companies. The move reflects a broader industry trend where large consumer packaged goods firms are diversifying into higher-margin, health-focused segments. Investors will observe how P&G balances the integration of Thorne with its existing portfolio, particularly in navigating the complex regulatory landscape and evolving consumer preferences within the dietary supplement industry over the next decade.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.
